DCTH
DELCATH SYSTEMS, INC.
Company overview
- Market capitalization
- $548.59M
- Employees
- 156
- Latest publication
- 2026-09-29
About DELCATH SYSTEMS, INC.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q1 20242024-03-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 29,133,000USD | 20,563,000USD | 24,156,000USD | 19,784,000USD | 15,100,000USD | 3,139,000USD | 434,000USD | 495,000USD |
| Cost Of Revenue | 2,985,000USD | 2,624,000USD | 3,318,000USD | 2,845,000USD | 2,126,000USD | 903,000USD | 133,000USD | 150,000USD |
| Gross Profit | 26,148,000USD | 17,939,000USD | 20,838,000USD | 16,939,000USD | 12,974,000USD | 2,236,000USD | 301,000USD | 345,000USD |
| Research Development | 10,380,000USD | 7,986,000USD | 6,882,000USD | 5,007,000USD | 2,914,000USD | 3,700,000USD | 4,662,000USD | 3,555,000USD |
| Selling General Administrative | 13,373,000USD | 10,341,000USD | 11,366,000USD | 11,290,000USD | 7,021,000USD | 8,814,000USD | 6,195,000USD | 4,787,000USD |
| Total Operating Expenses | 23,753,000USD | 18,327,000USD | 18,248,000USD | 16,297,000USD | 9,935,000USD | 12,514,000USD | 10,857,000USD | 8,342,000USD |
| Operating Income | 2,395,000USD | -388,000USD | 2,590,000USD | 642,000USD | 3,039,000USD | -10,278,000USD | -10,556,000USD | -7,997,000USD |
| Total Other Income Expense Net | 764,000USD | 763,000USD | 615,000USD | 622,000USD | -6,437,000USD | -833,000USD | -9,784,000USD | 795,000USD |
| Income Before Tax | 3,159,000USD | 375,000USD | 3,205,000USD | 1,264,000USD | -3,398,000USD | -11,111,000USD | -20,340,000USD | -7,202,000USD |
| Income Tax Expense | 491,000USD | -455,000USD | 508,000USD | 195,000USD | — | -14,276USD | -28,000USD | 377,000USD |
| Net Income | 2,668,000USD | 830,000USD | 2,697,000USD | 1,069,000USD | -3,398,000USD | -11,111,000USD | -20,340,000USD | -7,202,000USD |
| Interest Expense | — | 796,000USD | 649,000USD | — | — | 199,000USD | 395,000USD | 371,000USD |
| Net Interest Income | — | 796,000USD | 649,000USD | 618,000USD | 295,000USD | -199,000USD | -395,000USD | -371,000USD |
| Tax Provision | — | -455,000USD | 508,000USD | 195,000USD | — | — | — | — |
| Net Income From Continuing Ops | — | 830,000USD | 2,697,000USD | 1,069,000USD | -3,398,000USD | -11,111,000USD | -20,340,000USD | -7,202,000USD |
| Ebit | — | 375,000USD | 3,205,000USD | 1,264,000USD | 10,408,000USD | -10,912,000USD | -19,945,000USD | -6,831,000USD |
| Ebitda | — | 467,000USD | 3,232,000USD | 1,331,000USD | 10,477,000USD | -10,870,000USD | -19,655,000USD | -6,802,000USD |
| Depreciation And Amortization | — | 92,000USD | 27,000USD | 67,000USD | 69,000USD | 42,000USD | 290,000USD | 29,000USD |
| Reconciled Depreciation | — | 146,000USD | 27,000USD | 67,000USD | 69,000USD | 29,000USD | 28,000USD | 29,000USD |
| Interest Income | — | — | — | 618,000USD | — | — | — | — |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 1,166,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | -7,202,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20082008-12-31 · USD | FY 20062006-12-31 · USD | FY 20052005-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 85,231,000USD | 2,065,000USD | 1,646,000USD | 790,000USD | 346,000USD | — | — | — |
| Cost Of Revenue | 11,797,000USD | 635,000USD | 640,000USD | 464,000USD | 39,000USD | — | — | — |
| Gross Profit | 73,434,000USD | 1,430,000USD | 1,006,000USD | 326,000USD | 307,000USD | — | — | — |
| Research Development | 29,246,000USD | 17,502,000USD | 11,201,000USD | 12,688,000USD | 26,215,000USD | 5,378,335USD | 2,718,084USD | 1,744,251USD |
| Selling General Administrative | 43,528,000USD | 18,973,000USD | 11,108,000USD | 20,657,000USD | 27,963,000USD | 2,687,688USD | 8,980,424USD | 1,367,344USD |
| Total Operating Expenses | 72,774,000USD | 39,612,000USD | 22,309,000USD | 33,345,000USD | 54,178,000USD | 8,066,023USD | 11,698,508USD | 3,111,595USD |
| Operating Income | 660,000USD | -38,182,000USD | -21,303,000USD | -33,019,000USD | -53,871,000USD | -8,066,023USD | -11,698,508USD | -3,111,595USD |
| Net Interest Income | 2,920,000USD | -2,099,000USD | -175,000USD | — | — | — | — | — |
| Income Before Tax | 3,510,000USD | -47,678,000USD | -24,156,000USD | -30,324,000USD | -51,868,000USD | -6,864,885,000USD | -11,572,008USD | — |
| Income Tax Expense | 810,000USD | -39,895USD | 329,000USD | 81,000USD | 175,000USD | -6,858,020,115USD | -746,903USD | -246,976USD |
| Tax Provision | 810,000USD | — | — | — | — | — | — | — |
| Net Income | 2,700,000USD | -47,678,000USD | -24,156,000USD | -30,324,000USD | -51,868,000USD | -6,864,885USD | -10,951,605USD | -2,864,619USD |
| Net Income From Continuing Ops | 2,700,000USD | -45,014,000USD | -24,156,000USD | — | — | — | — | — |
| Ebit | 3,510,000USD | -46,239,000USD | -23,981,000USD | -30,324,000USD | -53,871,000USD | -6,864,884USD | -10,951,605USD | -2,864,619USD |
| Ebitda | 3,859,000USD | -45,840,000USD | -23,814,000USD | -29,198,000USD | -52,540,000USD | -6,859,023USD | -10,947,770USD | -2,858,567USD |
| Depreciation And Amortization | 349,000USD | 399,000USD | 167,000USD | 1,126,000USD | 1,331,000USD | 5,861USD | 3,835USD | 6,052USD |
| Reconciled Depreciation | 349,000USD | 121,000USD | 192,000USD | — | — | — | — | — |
| Total Other Income Expense Net | 2,850,000USD | -9,496,000USD | -2,853,000USD | 2,695,000USD | 2,003,000USD | -6,856,818,977USD | 126,500USD | 246,976USD |
| Unclassified Operating Expenses | — | 3,137,000USD | — | — | — | — | — | — |
| Interest Expense | — | 1,439,000USD | 175,000USD | 81,000USD | 175,000USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | -24,211,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 137,018,000USD | 124,838,000USD | 123,632,000USD | 124,295,000USD | 116,876,000USD | 87,319,000USD | 76,589,000USD | 31,681,000USD |
| Cash And Equivalents | 47,521,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 130,536,000USD | 120,269,000USD | 119,530,000USD | 120,615,000USD | 113,482,000USD | 84,349,000USD | 73,760,000USD | 28,882,000USD |
| Other Current Assets | 6,979,000USD | 5,899,000USD | 5,303,000USD | 6,498,000USD | 5,181,000USD | 3,940,000USD | 2,534,000USD | 1,312,000USD |
| Total Liabilities | 15,873,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 13,279,000USD | 10,698,000USD | 10,950,000USD | 8,010,999USD | 10,435,000USD | 5,287,000USD | 6,144,000USD | 21,584,000USD |
| Other Current Liabilities | 9,072,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 327,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 121,145,000USD | 112,710,000USD | 111,219,000USD | 114,847,000USD | 104,986,000USD | 80,230,000USD | 68,746,000USD | 8,571,000USD |
| Total Equity Including Noncontrolling Interest | 121,145,000USD | — | — | — | — | — | — | — |
| Net Receivables | 15,942,000USD | 15,263,000USD | 12,939,000USD | 14,460,000USD | 16,773,000USD | 14,381,000USD | 11,060,000USD | 6,936,000USD |
| Inventory | 11,713,000USD | 9,808,000USD | 10,252,000USD | 10,745,000USD | 10,523,000USD | 7,132,000USD | 6,933,000USD | 6,642,000USD |
| Property Plant Equipment Net | 6,482,000USD | 4,569,000USD | 4,102,000USD | 3,680,000USD | 3,394,000USD | 2,970,000USD | 2,829,000USD | 2,799,000USD |
| Accounts Payable | 4,011,000USD | 3,463,000USD | 2,658,000USD | 2,133,000USD | 4,716,000USD | 1,619,000USD | 961,000USD | 937,000USD |
| Short Term Debt | 196,000USD | 92,000USD | 101,000USD | 110,000USD | 116,000USD | 110,000USD | 105,000USD | 2,107,000USD |
| Common Stock | 346,000USD | 344,000USD | 347,000USD | 353,000USD | 350,000USD | 334,000USD | 331,000USD | 280,000USD |
| Retained Earnings | -527,250,000USD | -529,918,000USD | -528,848,000USD | -526,952,000USD | -527,782,000USD | -530,479,000USD | -531,548,000USD | -528,150,000USD |
| Accumulated Other Comprehensive Income | 258,000USD | 571,000USD | 575,000USD | 875,000USD | 592,000USD | 381,000USD | 82,000USD | 11,000USD |
| Total Liab | — | 12,128,000USD | 12,413,000USD | 9,448,000USD | 11,890,000USD | 7,089,000USD | 7,843,000USD | 23,110,000USD |
| Other Current Liab | — | 7,143,000USD | 8,191,000USD | 5,767,999USD | 5,603,000USD | 3,558,000USD | 5,078,000USD | 18,540,000USD |
| Capital Stock | — | 344,000USD | 347,000USD | 353,000USD | 350,000USD | 334,000USD | 331,000USD | 280,000USD |
| Cash | — | 41,313,000USD | 43,454,000USD | 41,813,000USD | 34,421,000USD | 12,776,000USD | 32,412,000USD | 8,315,000USD |
| Cash And Short Term Investments | — | 89,299,000USD | 91,036,000USD | 88,912,000USD | 81,005,000USD | 58,896,000USD | 53,233,000USD | 13,992,000USD |
| Net Debt | — | -40,406,000USD | -42,518,000USD | -40,848,000USD | -33,428,000USD | -11,760,000USD | -31,374,000USD | -5,245,000USD |
| Short Long Term Debt Total | — | 907,000USD | 936,000USD | 965,000USD | 993,000USD | 1,016,000USD | 1,038,000USD | 3,070,000USD |
| Short Term Investments | — | 47,986,000USD | 47,582,000USD | 47,099,000USD | 46,584,000USD | 46,120,000USD | 20,821,000USD | 5,677,000USD |
| Property Plant Equipment Gross | — | 9,909,000USD | 9,350,000USD | 8,848,000USD | 8,497,000USD | 7,985,000USD | 7,783,000USD | 7,748,000USD |
| Common Stock Shares Outstanding | — | 36,021,210shares | 39,847,530shares | 40,056,814shares | 40,262,764shares | 39,511,120shares | 28,447,989shares | 32,345,672shares |
| Non Current Assets Total | — | 4,569,000USD | 4,102,000USD | 3,680,000USD | 3,394,000USD | 2,970,000USD | 2,829,000USD | 2,799,000USD |
| Non Current Liabilities Total | — | 1,430,000USD | 1,463,000USD | 1,437,000USD | 1,455,000USD | 1,802,000USD | 1,699,000USD | 1,526,000USD |
| Non Current Liabilities Other | — | 615,000USD | 628,000USD | 582,000USD | 578,000USD | 896,000USD | 766,000USD | 563,000USD |
| Net Working Capital | — | 109,571,000USD | 108,580,000USD | 112,604,000USD | 103,047,000USD | 79,062,000USD | 67,616,000USD | 7,298,000USD |
| Unclassified Equity | — | 641,369,000USD | 638,798,000USD | 640,218,000USD | 631,476,000USD | 609,660,000USD | 599,550,000USD | 536,150,000USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 2,000,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -2,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 123,632,000USD | 76,589,000USD | 38,613,000USD | 17,862,000USD | 33,124,000USD | 34,635,000USD | 14,212,000USD | 6,844,000USD |
| Other Current Assets | 5,303,000USD | 2,534,000USD | 899,000USD | 6,120,000USD | 6,894,000USD | 2,851,000USD | 1,940,000USD | 1,381,000USD |
| Total Liab | 12,413,000USD | 7,843,000USD | 22,836,000USD | 23,721,000USD | 21,172,000USD | 12,557,000USD | 20,569,000USD | 21,783,000USD |
| Total Stockholder Equity | 111,219,000USD | 68,746,000USD | 15,777,000USD | -5,859,000USD | 11,952,000USD | 22,078,000USD | -6,357,000USD | -14,939,000USD |
| Other Current Liab | 8,191,000USD | 5,078,000USD | 5,249,000USD | 4,685,000USD | 4,109,000USD | 5,241,000USD | 10,315,000USD | 7,997,000USD |
| Common Stock | 347,000USD | 331,000USD | 228,000USD | 100,000USD | 79,000USD | 60,000USD | 1,000USD | 103,000USD |
| Capital Stock | 347,000USD | 331,000USD | 228,000USD | 100,000USD | 79,000USD | 60,000USD | 1,000USD | 103,000USD |
| Retained Earnings | -528,848,000USD | -531,548,000USD | -505,162,000USD | -457,484,000USD | -420,976,000USD | -395,327,000USD | -371,171,000USD | -344,054,000USD |
| Cash | 43,454,000USD | 32,412,000USD | 12,646,000USD | 7,671,000USD | 22,802,000USD | 28,575,000USD | 10,002,000USD | 2,516,000USD |
| Cash And Short Term Investments | 91,036,000USD | 53,233,000USD | 32,454,000USD | 7,671,000USD | 22,802,000USD | 28,575,000USD | 10,002,000USD | 2,516,000USD |
| Total Current Assets | 119,530,000USD | 73,760,000USD | 37,158,000USD | 16,155,000USD | 31,152,000USD | 32,338,000USD | 12,617,000USD | 5,919,000USD |
| Total Current Liabilities | 10,950,000USD | 6,144,000USD | 16,448,000USD | 14,735,000USD | 5,954,000USD | 10,035,000USD | 15,994,000USD | 17,750,000USD |
| Net Debt | -42,518,000USD | -31,374,000USD | -2,459,000USD | 8,203,000USD | -6,547,000USD | -25,630,000USD | -7,141,000USD | -478,000USD |
| Short Term Debt | 101,000USD | 105,000USD | 10,187,000USD | 8,032,000USD | 1,037,000USD | 2,495,000USD | 664,000USD | 2,038,000USD |
| Short Long Term Debt Total | 936,000USD | 1,038,000USD | 10,187,000USD | 15,874,000USD | 16,255,000USD | 2,945,000USD | 2,861,000USD | 2,038,000USD |
| Short Term Investments | 47,582,000USD | 20,821,000USD | 19,808,000USD | 0USD | — | — | — | — |
| Net Receivables | 12,939,000USD | 11,060,000USD | 483,000USD | 366,000USD | 44,000USD | 57,000USD | 21,000USD | 1,164,000USD |
| Inventory | 10,252,000USD | 6,933,000USD | 3,322,000USD | 1,998,000USD | 1,412,000USD | 855,000USD | 654,000USD | 858,000USD |
| Accounts Payable | 2,658,000USD | 961,000USD | 1,012,000USD | 2,018,000USD | 638,000USD | 1,774,000USD | 4,533,000USD | 7,715,000USD |
| Property Plant Equipment Net | 4,102,000USD | 2,829,000USD | 1,455,000USD | 1,707,000USD | 1,972,000USD | 2,297,000USD | 1,595,000USD | 925,000USD |
| Property Plant Equipment Gross | 9,350,000USD | 7,783,000USD | 6,530,000USD | 6,638,000USD | 1,972,000USD | 1,351,000USD | 1,595,000USD | 925,000USD |
| Accumulated Other Comprehensive Income | 575,000USD | 82,000USD | 135,000USD | -83,000USD | 18,000USD | -104,000USD | 28,000USD | 50,000USD |
| Common Stock Shares Outstanding | 39,919,557shares | 28,511,393shares | 16,229,931shares | 8,864,615shares | 7,145,754shares | 2,897,827shares | 25,900shares | 38shares |
| Non Current Assets Total | 4,102,000USD | 2,829,000USD | 1,455,000USD | 1,707,000USD | 1,972,000USD | 2,297,000USD | 1,595,000USD | 925,000USD |
| Non Current Liabilities Total | 1,463,000USD | 1,699,000USD | 6,388,000USD | 8,986,000USD | 15,218,000USD | 2,522,000USD | 4,575,000USD | 4,033,000USD |
| Non Current Liabilities Other | 628,000USD | 766,000USD | 840,000USD | 1,144,000USD | 207,000USD | — | — | 628,000USD |
| Net Working Capital | 108,580,000USD | 67,616,000USD | 20,710,000USD | 1,420,000USD | 25,198,000USD | 22,303,000USD | -2,895,000USD | -11,831,000USD |
| Unclassified Equity | 638,798,000USD | 599,550,000USD | 520,348,000USD | 451,508,000USD | 432,752,000USD | 417,389,000USD | 364,784,000USD | 328,859,000USD |
| Other Assets | — | — | 1USD | — | — | 946,000USD | — | — |
| Short Long Term Debt | — | — | 10,150,000USD | 7,846,000USD | 621,000USD | 2,000,000USD | — | 2,038,000USD |
| Non Currrent Assets Other | — | — | -1USD | -1,707,000USD | -1,972,000USD | -2,297,000USD | -1,595,000USD | — |
| Unclassified Current Liabilities | — | — | -10,150,000USD | -7,846,000USD | — | -2,000,000USD | — | -5,443,000USD |
| Unclassified Non Current Liabilities | — | — | 5,548,000USD | -1,062,000USD | — | — | — | — |
| Other Liab | — | — | — | 1,062,000USD | — | 2,072,000USD | 2,860,000USD | 4,033,000USD |
| Long Term Debt | — | — | — | 7,842,000USD | 15,011,000USD | — | 2,000,000USD | — |
| Net Tangible Assets | — | — | — | -5,859,000USD | 11,952,000USD | 22,078,000USD | -6,357,000USD | -14,939,000USD |
| Current Deferred Revenue | — | — | — | — | 170,000USD | 525,000USD | 482,000USD | 3,405,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,070,000USD | -1,896,000USD | 830,000USD | 2,697,000USD | 1,069,000USD | -3,398,000USD | 1,864,000USD | -13,741,000USD |
| Depreciation | 131,000USD | 109,000USD | 146,000USD | 81,000USD | 67,000USD | 69,000USD | 31,000USD | 20,000USD |
| Stock Based Compensation | 4,946,000USD | 4,512,000USD | 5,648,000USD | 7,209,000USD | 6,863,000USD | 1,612,000USD | 2,141,000USD | 3,069,000USD |
| Other Non Cash Items | -440,000USD | -458,000USD | -527,000USD | -459,000USD | -306,000USD | 5,708,000USD | -13,487,000USD | 9,868,000USD |
| Change To Account Receivables | -2,415,000USD | 2,007,000USD | 2,085,000USD | -1,894,000USD | -3,052,000USD | -3,954,000USD | -3,210,000USD | -2,162,000USD |
| Change To Inventory | 444,000USD | 493,000USD | -222,000USD | -3,391,000USD | -199,000USD | -291,000USD | -326,000USD | -2,682,000USD |
| Change In Working Capital | -2,710,000USD | 5,981,000USD | -1,325,000USD | -2,235,000USD | -5,490,000USD | -4,997,000USD | 5,811,000USD | -3,667,000USD |
| Total Cash From Operating Activities | 857,000USD | 8,248,000USD | 4,772,000USD | 7,293,000USD | 2,203,000USD | -1,006,000USD | -3,640,000USD | -4,451,000USD |
| Capital Expenditures | -570,000USD | -550,000USD | -459,000USD | -398,000USD | -140,000USD | -229,000USD | -216,000USD | -101,000USD |
| Free Cash Flow | 287,000USD | 7,698,000USD | 4,313,000USD | 6,895,000USD | 2,063,000USD | -1,235,000USD | -3,856,000USD | -4,552,000USD |
| Investments | -1,000USD | -11,000USD | -466,000USD | -415,000USD | -25,148,000USD | -15,228,000USD | -697,000USD | 10,284,000USD |
| Total Cashflows From Investing Activities | -571,000USD | -561,000USD | -466,000USD | -415,000USD | -25,148,000USD | -15,228,000USD | -697,000USD | 10,284,000USD |
| Total Cash From Financing Activities | -2,381,000USD | -5,944,000USD | 3,100,000USD | 14,639,000USD | 3,253,000USD | 40,385,000USD | -2,142,000USD | -2,854,000USD |
| Sale Purchase Of Stock | -3,000,000USD | -6,000,000USD | 243,000USD | 238,000USD | 0USD | — | 175,000USD | — |
| Change In Cash | -2,141,000USD | 1,641,000USD | 7,392,000USD | 21,645,000USD | -19,636,000USD | 24,097,000USD | -6,467,000USD | 2,972,000USD |
| Begin Period Cash Flow | 43,454,000USD | 41,813,000USD | 34,421,000USD | 12,776,000USD | 32,412,000USD | 8,315,000USD | 14,782,000USD | 11,810,000USD |
| End Period Cash Flow | 41,313,000USD | 43,454,000USD | 41,813,000USD | 34,421,000USD | 12,776,000USD | 32,412,000USD | 8,315,000USD | 14,782,000USD |
| Net Borrowings | — | 0USD | 0USD | 0USD | 0USD | -2,000,000USD | -2,503,000USD | — |
| Issuance Of Capital Stock | — | 481,000USD | -238,000USD | 238,000USD | 0USD | 250,000USD | -75,000USD | -154,000USD |
| Other Cashflows From Financing Activities | — | -5,944,000USD | 3,100,000USD | 14,401,000USD | 3,253,000USD | 42,135,000USD | 436,000USD | 353,000USD |
| Unclassified Financing Cash Flow | — | 6,000,000USD | — | — | — | — | — | -3,053,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 10,385,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -10,284,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2,700,000USD | -26,386,000USD | -47,678,000USD | -36,508,000USD | -25,649,000USD | -24,156,000USD | -8,879,000USD | -19,222,000USD |
| Depreciation | 349,000USD | 229,000USD | 128,000USD | 132,000USD | 146,000USD | 192,000USD | 249,000USD | 444,000USD |
| Stock Based Compensation | 24,232,000USD | 9,767,000USD | 8,151,000USD | 7,941,000USD | 7,832,000USD | 3,911,000USD | 277,000USD | 58,000USD |
| Other Non Cash Items | -1,696,000USD | 13,230,000USD | 9,054,000USD | 1,371,000USD | 831,000USD | 159,000USD | -9,774,000USD | 7,973,000USD |
| Change To Account Receivables | -854,000USD | -10,649,000USD | 125,000USD | -322,000USD | 13,000USD | -36,000USD | 497,000USD | -293,000USD |
| Change To Inventory | -3,319,000USD | -3,611,000USD | -1,324,000USD | -587,000USD | -557,000USD | -201,000USD | 204,000USD | 385,000USD |
| Change In Working Capital | -3,069,000USD | -15,521,000USD | -906,000USD | 2,114,000USD | -5,764,000USD | -5,806,000USD | -5,562,000USD | 11,772,000USD |
| Total Cash From Operating Activities | 22,516,000USD | -18,681,000USD | -31,251,000USD | -24,950,000USD | -22,604,000USD | -22,868,000USD | -23,689,000USD | -14,732,000USD |
| Capital Expenditures | -1,547,000USD | -559,000USD | -58,000USD | -209,000USD | -143,000USD | -782,000USD | -24,000USD | -76,000USD |
| Free Cash Flow | 20,969,000USD | -19,240,000USD | -31,309,000USD | -25,159,000USD | -22,747,000USD | -23,650,000USD | -23,713,000USD | -14,808,000USD |
| Investments | -25,043,000USD | -981,000USD | -39,000USD | -209,000USD | -143,000USD | -782,000USD | -24,000USD | -76,000USD |
| Total Cashflows From Investing Activities | -26,590,000USD | -981,000USD | -19,709,000USD | -209,000USD | -143,000USD | -782,000USD | -24,000USD | -76,000USD |
| Net Borrowings | 0USD | -10,610,000USD | -6,313,000USD | -714,000USD | 14,437,000USD | -26,000USD | 3,680,000USD | 794,000USD |
| Total Cash From Financing Activities | 15,048,000USD | 39,410,000USD | 51,778,000USD | 10,143,000USD | 20,822,000USD | 42,355,000USD | 30,305,000USD | 13,236,000USD |
| Sale Purchase Of Stock | -6,000,000USD | 250,000USD | 123,000USD | 10,857,000USD | — | -107,000USD | — | 0USD |
| Issuance Of Capital Stock | 481,000USD | 7,021,000USD | 29,044,000USD | 10,857,000USD | 20,317,000USD | 39,764,000USD | 26,625,000USD | 11,922,000USD |
| Change In Cash | 11,042,000USD | 19,716,000USD | 874,000USD | -15,131,000USD | -1,803,000USD | 18,573,000USD | 6,606,000USD | -1,746,000USD |
| Begin Period Cash Flow | 32,412,000USD | 12,696,000USD | 11,822,000USD | 26,953,000USD | 28,756,000USD | 10,183,000USD | 3,577,000USD | 5,324,000USD |
| End Period Cash Flow | 43,454,000USD | 32,412,000USD | 12,696,000USD | 11,822,000USD | 26,953,000USD | 28,756,000USD | 10,183,000USD | 3,578,000USD |
| Other Cashflows From Financing Activities | 15,048,000USD | 42,999,000USD | 35,008,000USD | -209,000USD | 2,462,000USD | 2,617,000USD | 26,625,000USD | 13,447,000USD |
| Unclassified Financing Cash Flow | 6,000,000USD | 6,771,000USD | 74,738,000USD | — | -16,394,000USD | 39,978,000USD | -26,625,000USD | -1,005,000USD |
| Dividends Paid | — | — | -51,778,000USD | — | — | -107,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | -19,612,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | 2,419,000USD | -3,563,000USD | -4,659,000USD | -5,270,000USD | 11,666,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -15,016,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | 2,832,000USD | — | -15,757,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | International | 1,972,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 27,161,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | CHEMOSAT | 1,972,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | HEPZATOKIT | 27,161,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 1,747,000 | USD | 0001628280-26-031751 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 23,247,000 | USD | 0001628280-26-031751 |
| Q1 2026Quarterly · 2026-03-31 | Product | CHEMOSAT | 1,747,000 | USD | 0001628280-26-031751 |
| Q1 2026Quarterly · 2026-03-31 | Product | HEPZATOKIT | 23,247,000 | USD | 0001628280-26-031751 |
| Q4 2025Quarterly · 2025-12-31 | Product | CHEMOSAT | 1,669,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | HEPZATOKIT | 19,059,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 6,396,000 | USD | 0001628280-26-012019 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 78,835,000 | USD | 0001628280-26-012019 |
| FY 2025Yearly · 2025-12-31 | Product | CHEMOSAT | 6,396,000 | USD | 0001628280-26-012019 |
| FY 2025Yearly · 2025-12-31 | Product | HEPZATOKIT | 78,835,000 | USD | 0001628280-26-012019 |
| Q3 2025Quarterly · 2025-09-30 | Product | CHEMOSAT | 1,310,000 | USD | 0001628280-25-048558 |
| Q3 2025Quarterly · 2025-09-30 | Product | HEPZATOKIT | 19,253,000 | USD | 0001628280-25-048558 |
| Q2 2025Quarterly · 2025-06-30 | Product | CHEMOSAT | 1,656,000 | USD | 0001628280-25-038112 |
| Q2 2025Quarterly · 2025-06-30 | Product | HEPZATOKIT | 22,500,000 | USD | 0001628280-25-038112 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 1,761,000 | USD | 0001628280-26-031751 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 18,023,000 | USD | 0001628280-26-031751 |
| Q1 2025Quarterly · 2025-03-31 | Product | CHEMOSAT | 1,761,000 | USD | 0001628280-26-031751 |
| Q1 2025Quarterly · 2025-03-31 | Product | HEPZATOKIT | 18,023,000 | USD | 0001628280-26-031751 |
| Q4 2024Quarterly · 2024-12-31 | Product | CHEMOSAT | 1,412,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | HEPZATOKIT | 13,688,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 4,902,000 | USD | 0001628280-26-012019 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 32,303,000 | USD | 0001628280-26-012019 |
| FY 2024Yearly · 2024-12-31 | Product | CHEMOSAT | 4,902,000 | USD | 0001628280-26-012019 |
| FY 2024Yearly · 2024-12-31 | Product | HEPZATOKIT | 32,303,000 | USD | 0001628280-26-012019 |
| Q3 2024Quarterly · 2024-09-30 | Product | CHEMOSAT | 1,163,000 | USD | 0001628280-25-048558 |
| Q3 2024Quarterly · 2024-09-30 | Product | HEPZATOKIT | 10,037,000 | USD | 0001628280-25-048558 |
| FY 2023Yearly · 2023-12-31 | Product | CHEMOSAT | 2,065,000 | USD | 0001628280-25-010797 |
| FY 2023Yearly · 2023-12-31 | Product | HEPZATOKIT | 0 | USD | 0001628280-25-010797 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 2,548,000 | USD | 0001628280-24-013008 |
| FY 2022Yearly · 2022-12-31 | Product | Product And Service Other | 171,000 | USD | 0001628280-24-013008 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 1,300,000 | USD | 0001193125-23-079836 |
| FY 2021Yearly · 2021-12-31 | Product | Product And Service Other | 2,255,000 | USD | 0001193125-23-079836 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.